Early assessment of metabolic and cardiovascular risk.

Comprehensive Cardiovascular and Metabolic Panel

This panel is for early assessment of metabolic and cardiovascular risk, using carefully selected tests that identify early metabolic deviations indicating disease risk. This panel has been selected to identify physiological changes oftentimes evident before the manifestation of common metabolic syndrome risk factors, to aid practitioners in identifying risk and delaying or preventing disease progression. These markers have been tested overtime by medical and scientific community and found to be implicated in a wide range of cardiovascular and metabolic disorders. Knowing these markers will have a profound impact on implementing lifestyle modifications and correcting any ensuing disorders that can otherwise prove fatal.

HEART FAILURE MARKERS

• B-Type Natriuretic Peptide (BNP)
• ST2, Soluble
• Galectin-3
• Troponin T, High Sensitivity (hs-TnT)
• INFLAMMATORY MARKERS
• hs-CRP
• Lp-PLA2 Activity
• Myeloperoxidase (MPO)
• F2-Isoprostane/Creatinine Ratio

METABOLIC RISK MARKERS

• TMAO (Trimethylamine N-Oxide)
• Homocysteine
• Kidney Profile (EGFR, Creatinine)
• Lp-PLA2 Activitya
• C-peptide assay
• Insulin, Intact, LC/MS/MS
• Hemoglobin A1c
• Apolipoprotein B
• Angiotensin II Type 1 Receptor (AGTR1) Gene Polymorphism
• Albumin, Random Urine with Creatinine
• Angiotensin Converting Enzyme (ACE) Polymorphism 
• ADMA/SDMA